Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.
Cardiovasc Interv Ther. 2023 Jul;38(3):269-274. doi: 10.1007/s12928-023-00930-1. Epub 2023 Mar 27.
Recently, there has been a growing interest in the concept of complex and high-risk intervention in indicated patients (CHIP). In our previous studies, we defined the three CHIP components (complex PCI, patient factors, and complicated heart disease), and introduced a novel stratification based on patient factors and/or complicated heart disease. We divided patients undergoing complex PCI into the definite CHIP, the possible CHIP, and the non-CHIP groups. Definite CHIP was defined as complex PCI for patients with both patient factors and complicated heart disease, and possible CHIP was defined as complex PCI for patients with either patient factors or complicated heart disease. Of note, even if a patient has both patients' factors and complicated heart disease, non-complex PCI is not a CHIP-PCI. In this review article, we discussed the determinants of complications in CHIP-PCI, long-term outcomes after CHIP-PCI, mechanical circulatory support devices for CHIP-PCI, and the goal of CHIP-PCI. Although CHIP-PCI attracts rising attention in contemporary PCI, clinical studies that investigate the clinical implications of CHIP-PCI are still sparse. Further studies are warranted to optimize CHIP-PCI.
最近,人们对有指征患者的复杂和高危介入治疗(CHIP)概念越来越感兴趣。在我们之前的研究中,我们定义了 CHIP 的三个组成部分(复杂 PCI、患者因素和复杂心脏病),并根据患者因素和/或复杂心脏病引入了一种新的分层方法。我们将接受复杂 PCI 的患者分为明确 CHIP、可能 CHIP 和非 CHIP 组。明确 CHIP 定义为同时具有患者因素和复杂心脏病的患者的复杂 PCI,可能 CHIP 定义为仅具有患者因素或复杂心脏病的患者的复杂 PCI。值得注意的是,即使患者同时具有患者因素和复杂心脏病,非复杂 PCI 也不是 CHIP-PCI。在这篇综述文章中,我们讨论了 CHIP-PCI 并发症的决定因素、CHIP-PCI 后的长期结果、CHIP-PCI 用机械循环支持设备以及 CHIP-PCI 的目标。尽管 CHIP-PCI 在当代 PCI 中受到越来越多的关注,但研究 CHIP-PCI 临床意义的临床研究仍然很少。需要进一步的研究来优化 CHIP-PCI。